Zhixiang Zhuang

机构：Soochow University, Zhangjiagang First People's Hospital, Second Affiliated Hospital of Soochow University · ORCID：0000-0001-7262-3440

发表论文 48 篇 · 总被引 434 次 · h-index 12

代表论文

• Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial (2025 · The Lancet Oncology · 被引 61)
• A phase 1 trial of claudin 18.2-specific antibody-drug conjugate CMG901 in patients with advanced gastric/gastroesophageal junction cancer. (2023 · Journal of Clinical Oncology · 被引 22)
• Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic/recurrent NSCLC patients with EGFR mutation from a phase I/IIa study (2023 · BMC Medicine · 被引 13)
• Gunagratinib, a highly selective irreversible FGFR inhibitor, in patients with previously treated locally advanced or metastatic cholangiocarcinoma harboring FGFR pathway alterations: A phase IIa dose-expansion study. (2023 · Journal of Clinical Oncology · 被引 11)
• Efficacy and safety of KN026 and docetaxel for HER2‐positive breast cancer: a phase II clinical trial (2025 · 癌症：英文版 · 被引 9)
• Evaluation of the safety, pharmacokinetics, and efficacy of JSKN003 in patients with advanced solid tumors: A phase I/II clinical study. (2024 · Journal of Clinical Oncology · 被引 7)